Guildford, United Kingdom

Andrew Hope

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Reneuron, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Hope. Retrieved from https://idiyas.com/inventor/andrew-hope-naz5bpsp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrew Hope: Innovator in Cellular Therapies

Introduction

Andrew Hope is a notable inventor based in Guildford, GB. He has made significant contributions to the field of cellular therapies, particularly through his innovative patent. His work focuses on therapeutic compositions that have the potential to transform patient care.

Latest Patents

Andrew Hope holds a patent for "Cellular compositions for use in therapy." This invention provides a therapeutic composition that comprises specific cellular elements. The patent also details methods for formulating this composition for cryopreservation and subsequent direct administration to patients, along with medicaments that include this composition.

Career Highlights

Andrew is currently associated with Reneuron, Inc., where he continues to advance his research and development efforts. His work is pivotal in the realm of regenerative medicine, aiming to improve therapeutic outcomes for patients.

Collaborations

Andrew has collaborated with esteemed colleagues such as Erik Miljan and John Sinden. These partnerships have fostered a collaborative environment that enhances innovation and research in cellular therapies.

Conclusion

Andrew Hope's contributions to the field of cellular therapies through his patent and work at Reneuron, Inc. highlight his commitment to advancing medical science. His innovative approaches are paving the way for new therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…